PFE Stock Rises as Pfizer Requests FDA Approval of Covid-19 Treatment PaxlovidInvestorPlace • 06/30/22
Pfizer Announces Submission of New Drug Application to the U.S. FDA for PAXLOVID™Business Wire • 06/30/22
U.S. to pay $3.2 billion to Pfizer, BioNTech for more COVID-19 vaccines for fallMarket Watch • 06/29/22